Don is President of PCCI, a professional association that helps early-stage life science companies succeed. His areas of expertise include strategic healthcare marketing, business intelligence, reimbursement, the nursing crisis, the DME market, medical devices, hospital asset management, and the development of strategic business alliances. He has founded and run several companies in addition to Corporate Development Advisors.

Linda is an accomplished senior drug development and operations executive with documented success coordinating drug and biologics development, such as Omnipaque®, Omniscan®, Bexxar®, and Protonix® throughout all regulatory and clinical phases (from early stage investigation and proof of concept to completion of clinical trials, FDA approval, and post-marketing) for pharmaceutical, biotechnology and clinical CRO organizations.

Mark was Senior Director of Product Development at Bracco Diagnostics, Senior Market Manager of Magnetic Resonance Products at Bristol-Myers Squibb Diagnostics, a faculty member of the Department of Radiology at the University of Pennsylvania and Georgetown University.

Peter's Pharmaceutical Industry credits include positions with Merck in Spain (New Products Manager), Venezuela (Marketing Director), and the United States (International Group Manager Cardiovasculars), and with Wyeth in Spain (Deputy General Manager) and in the United States (Group Director European Operations).